SCHEMBL29052129

SCHEMBL29052129

CS(=O)(=O)CCn1nc(Br)c2c(N)ncnc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 7/20 0.45
▸ JAK3 P52333 7/20 0.45
▸ JAK1 P23458 5/20 0.45
▸ ADK P55263 3/20 0.42
▸ DYRK1A Q13627 1/20 0.39
▸ HDAC1 Q13547 2/20 0.38
▸ SRC P12931 2/20 0.38
▸ YES1 P07947 1/20 0.38
▸ FGR P09769 1/20 0.38
▸ ADORA2A P29274 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ PIK3CD O00329 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ PRKDC P78527 1/20 0.37
▸ RET P07949 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29781032 1.00 JAK2 (0.45) JAK2JAK3JAK1ADKDYRK1A
SCHEMBL29052149 0.82 ADORA2A (0.49) JAK2JAK3JAK1ADKDYRK1A
SCHEMBL29781034 0.82 ADORA2A (0.49) JAK2JAK3JAK1ADKDYRK1A
SCHEMBL21851263 0.80 ADORA2A (0.51) JAK2JAK3JAK1ADKDYRK1A
SCHEMBL19476278 0.80 ADORA2A (0.49) JAK2JAK3JAK1ADKDYRK1A
SCHEMBL29780904 0.80 JAK2 (0.46) JAK2JAK3JAK1ADKDYRK1A
SCHEMBL29052236 0.80 JAK2 (0.46) JAK2JAK3JAK1ADKDYRK1A
SCHEMBL29052189 0.78 SRC (0.55) SRCYES1FGRPIK3CDPIK3CA
SCHEMBL29781082 0.78 SRC (0.55) SRCYES1FGRPIK3CDPIK3CA
SCHEMBL19476294 0.77 RET (0.48) JAK2JAK3JAK1ADKDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116583287-A Pyridazinone heterocyclic compound, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-08-11 — — CN disclosed
Send feedback